By proceeding, you agree to our Terms of Use and Privacy Policy.
We are a new Canadian CMO specializing in the production of nucleic acid products that support life-enabling work. We support our clients by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field.
06-07 September 2023
LSX are known for bringing life science investors together to assess and meet with the most promising up-and-coming biotech companies. When the first mRNA vaccines hit the market in 2020, one of our investors asked us to look at the resurgence of the
Event Ended
USA
Paid
Boston